OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 117.4% based on the discounted cash flow analysis.
| Market cap | $7.23 Billion |
|---|---|
| Enterprise Value | $3.59 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.34 |
| Outstanding Shares | 302,220,000 |
| P/E Ratio | 16.32 |
|---|---|
| PEG | -6.31 |
| Price to Sales | 0.59 |
| Price to Book Ratio | 4.94 |
| Enterprise Value to Revenue | 0.23 |
| Enterprise Value to EBIT | 5.68 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8654▼ 20.76% |
|---|---|
| Total Calls | 931,800▼ 91.71% |
| Total Puts | 806,400▼ 93.32% |
Holdings and activity of institutional investors.
| Ownership % | 14.49%▼ 44.02% |
|---|---|
| Total Invested | $1.23B▼ 38.54% |
| Investors Holding | 171▼ 195.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...